Myriad Genetics, Inc.
LSE: 0K3W.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Samraat S. Raha
- Employees
- 2,700
- Headquarters
- Salt Lake City, United States
- IPO year
- 2018
- Market cap
- $412.6M
- Website
- https://myriad.com
Loading 0K3W…
Loading profile data…Frequently asked questions about 0K3W
What does Myriad Genetics, Inc. (0K3W.L) do?
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing...
Where does 0K3W.L trade?
Myriad Genetics, Inc. (0K3W.L) trades on the London Stock Exchange.
What sector is 0K3W.L in?
Myriad Genetics, Inc. (0K3W.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Myriad Genetics, Inc.?
Samraat S. Raha is the chief executive officer of Myriad Genetics, Inc. (0K3W.L).
Where is Myriad Genetics, Inc. headquartered?
Myriad Genetics, Inc. is headquartered in United States.
Does 0K3W.L pay a dividend?
Myriad Genetics, Inc. (0K3W.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0K3W.L go public?
Myriad Genetics, Inc. (0K3W.L) completed its initial public offering in 2018.